Clinical trial · Observational
A Prospective Study of EUS Guided Celiac Block
A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness
NCT00583271CI-TRIAL-00015549completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Pancreatitis | — | UNRESOLVED | — |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 98% dehydrated alcohol | Drug | — | UNRESOLVED |
| triamcinolone | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- subjects who are getting a celiac block for chronic pancreatitis
- interventionNames
- Drug: triamcinolone
- label
- 2
- description
- subjects who are getting a celiac block for pancreatic cancer
- interventionNames
- Drug: 98% dehydrated alcohol
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with chronic abdominal pain from documented chronic pancreatitis or pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for purposes other than this study) will be eligible to participate in this study. * Patients with chronic pancreatitis and pancreatic cancer must have documented disease by CT, ERCP, or EUS. * No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol. * Patient must provide signed written informed consent Exclusion Criteria: * Patients that have had a previous celiac plexus block are eligible for this study
References
Publications (0)
Data not yet available
No reference posted for this study.